Science1 publisher3 min readPublished
Many cognition studies behind nicotine's wellness pitch enrolled people already dependent on it
Wellness influencers, podcasters and startups now sell nicotine pouches for focus and against cognitive decline, and a pulmonary physician-scientist writing on phys.org says the human evidence points the other way for healthy users.
The Scientist · Science desk
What happened
- Wellness influencers, podcasters and tech startups are recasting nicotine as a misunderstood compound whose benefits were obscured by cigarettes, a trend emerging alongside the Make America Healthy Again movement.
- The products involved include nicotine pouches used on their own and nicotine combined with caffeine and nootropics, sold on the promise of sharper cognition.
- Repeated exposure leaves nicotinic receptors less responsive and prompts the brain to build more of them, the adaptation that contributes to dependence.
Compiled by The ScientistSomething wrong?How this is made
Why it matters
- constraint The evidence of benefit sits with people who have mild cognitive impairment, so a healthy adult buying a pouch for focus is buying outside the trial population.
- exposure The receptor adaptation stays when the tobacco goes, so a first-time user of a wellness-branded pouch is starting on the same dependence pathway.
- decision A clinician asked whether a pouch sharpens focus has to answer from studies of dependent users, and those studies lack a nicotine-naive baseline.
- precedent If noncombustible comes to mean benign in marketing, the raised heart rate, raised blood pressure and disrupted sleep the essay attributes to nicotine alone will sit outside the conversation.
Nicotine binds many of the same nicotinic acetylcholine receptors that respond to acetylcholine, and for a while it raises alertness, attention and arousal [9]. Its effects last far longer than acetylcholine's and they alter activity across the brain [10]. With repeated exposure the receptors become less responsive, the brain compensates by building more of them, and dependence follows from that adaptation [11]. Nicotine is the primary driver of tobacco addiction in cigarettes, vapes and most other commercial forms [5].
The cognition claims are harder to check than they look. Many of the studies reporting gains in attention and vigilance enrolled regular users who were already dependent on nicotine [14]. In that design the comparison available is a dependent person with nicotine against the same person without it [19]. That comparison leaves out the nicotine-naive baseline. The essay carries no trial names, no effect sizes and no regulatory or clinical response to the wellness pitch [17].
Some studies show temporary improvement in attention, vigilance, reaction time and parts of working memory, and the results are mixed [12]. Nicotine may benefit people with mild cognitive impairment; in healthy people it does not appear to enhance cognition, and in higher-performing people it may worsen performance [13]. Pouches and caffeine-plus-nootropic blends are sold to healthy people who want focus and protection against cognitive decline [2][3]. The people with evidence of benefit and the people buying the product are two different groups [18].
"As a pulmonary physician-scientist who studies nicotine addiction and the health consequences of tobacco and nicotine products, I am concerned about claims that nicotine can enhance wellness, productivity and cognitive performance," the author wrote [4].
The natural-product framing starts from a real fact: nicotine is a plant compound, found mostly in tobacco and in trace amounts in nightshade vegetables such as tomatoes, potatoes and eggplant [15]. Proponents also draw on studies showing that nicotine affects aspects of cognition and brain function [1]. Extending those findings into claims about productivity, brain health, longevity or wellness goes well beyond what human studies have shown, according to the essay [16].
The essay separates combustion from nicotine. The greatest health risks arise when tobacco is burned, which generates thousands of toxic substances including carcinogens, carbon monoxide and fine particulate matter, and repeated exposure can cause cancer, chronic obstructive pulmonary disease and cardiovascular disease [6]. On its own, nicotine activates the sympathetic nervous system, raising heart rate and blood pressure and disrupting sleep, and repeated stimulation can strain the heart [7]. Prenatal exposure has been associated with adverse effects on fetal growth and development, and adolescent exposure can alter the neural systems involved in attention, learning and reward, increasing vulnerability to addiction [8].
What to watch
- Trials in nicotine-naive healthy adults that report effect sizes on attention and working memory tasks would settle the enhancement question the essay leaves open.
- Whether regulators treat cognitive-benefit claims on nicotine pouches as marketing claims that require evidence.
- Whether pouch and nootropic sellers start naming the specific studies behind their focus and brain-health claims.